LYZ2-SH3b as a novel and efficient enzybiotic against methicillin-resistant Staphylococcus aureus

被引：0
作者：
Marzieh Asadi
Mortaza Taheri-Anganeh
Maryam Ranjbar
Seyyed Hossein Khatami
Amir Maleksabet
Zohreh Mostafavi-Pour
Younes Ghasemi
Abdolkhalegh Keshavarzi
Amir Savardashtaki
机构：
[1] Shiraz University of Medical Sciences Shiraz,Department of Medical Biotechnology, School of Advanced Medical Sciences and Technologies
[2] Shiraz University of Medical Sciences,Student Research Committee
[3] Urmia University of Medical Sciences,Cellular and Molecular Research Center, Cellular and Molecular Medicine Research Institute
[4] Shahid Beheshti University of Medical Sciences,Department of Clinical Biochemistry, School of Medicine
[5] Mazandaran University of Medical Sciences,Department of Medical Biotechnology, School of Advanced Technologies in Medicine
[6] Shiraz University of Medical Sciences,Recombinant Protein Laboratory, Department of Biochemistry, School of Medicine
[7] Shiraz University of Medical Science,Pharmaceutical Sciences Research Center
[8] Shiraz University of Medical Science,Burn and Wound Healing Research Center
[9] Shiraz University of Medical Sciences,Infertility Research Center
来源：
BMC Microbiology | / 23卷
关键词：
SH3b domain; Enzybiotic; MRSA; Exolysin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 111 条
[1]  
Lu Y(2021)Phage endolysin LysP108 showed promising antibacterial potential against methicillin-resistant Staphylococcus aureus Front Cell Infect Microbiol 11 668430-35
[2]  
Wang Y(2020)Bacteriocins, potent antimicrobial peptides and the fight against multi drug resistant species: resistance is futile? Antibiotics 9 32-80
[3]  
Wang J(2012)The Staphylococci phages family: an overview Viruses 4 3316-97
[4]  
Zhao Y(2016)Alternatives to overcoming bacterial resistances: state-of-the-art Microbiol Res 191 51-43
[5]  
Zhong Q(2017)A review of phage therapy against bacterial pathogens of aquatic and terrestrial organisms Viruses 9 50-16
[6]  
Li G(2021)Engineering of the CHAPk staphylococcal phage endolysin to enhance antibacterial activity against stationary-phase cells Antibiotics 10 722-13
[7]  
Meade E(2020)Enzybiotics LYSSTAPH-S and LYSDERM-S as potential therapeutic agents for chronic MRSA Wound Infections Antibiotics 9 519-30
[8]  
Slattery MA(2020)A potent enzybiotic against methicillin-resistant Staphylococcus aureus Virus Genes 56 480-14
[9]  
Garvey M(2018)The Auxiliary Role of the Amidase Domain in Cell Wall binding and exolytic activity of staphylococcal phage endolysins Viruses 10 284-76
[10]  
Deghorain M(2018)Endolysins of bacteriophages as an anti-methicillin resistant staphylococcus aureus infection in children: a narrative review J Pediatr Rev 6 36-10
12345678910